Twist Bioscience Corporation TWST
105.04 USD -6.56 (-5.88%)
Regular-session close
103.50 -1.54 -1.47%
After hours · Nov 16, 6:59 PM ET
101.05 Day range 106.28
24.41 52-week range 219.71
- YTD
- +231.15%
- 1 year
- +290.92%
News
seekingalpha.com Twist Bioscience: Long-Term 'Buy' On AI Discovery For Biotech I believe TWST can, over time, capture more of a customer's R&D budget if initial DNA orders lead to more repeat testing and lab data work. TWST's AI drug discovery is at the heart of my growth bull…benzinga.com Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $130 Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.
benzinga.com CrowdStrike To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday Analysts raised CrowdStrike and Jazz targets, while cutting targets for Cisco, Fermi, Twist Bioscience, Applied Materials, Firefly and Nebius.benzinga.com Leerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175 Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $190 to $175.
benzinga.com TD Cowen Maintains Buy on Twist Bioscience, Lowers Price Target to $137 TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $190 to $137.
247wallst.com Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir ARK stepped into a sliding AI infrastructure stock while quietly trimming a premium-priced winner. One date next week could decide whether that bet on debt-fueled growth was savvy or early.benzinga.com Canaccord Genuity Maintains Buy on Twist Bioscience, Lowers Price Target to $150 Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $205 to $150.
benzinga.com Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $135 Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $187 to $135.
marketbeat.com Twist Bioscience Q4 Earnings Call Highlights Twist Bioscience NASDAQ: TWST reported 28% revenue growth and positive adjusted EBITDA for its fiscal fourth quarter, as demand for DNA, proteins and data used in AI drug discovery helped drive a 22%…
fool.com Twist Bioscience: 3 Key Takeaways for Long-Term Investors Fourth-quarter revenue grew 28% year over year to $126.6 million. AI drug discovery revenue reached $59.1 million in fiscal 2026.
seekingalpha.com Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript
seekingalpha.com Alger Mid Cap 40 ETF Q3 2026 Portfolio Review Twist Bioscience Corp., Cloudflare Inc., and Repligen Corporation were among the top contributors to performance. We believe Cloudflare's extensive network and expanding product portfolio position it…
benzinga.com Twist Bioscience 2027 Outlook Signals Sharp Slowdown in AI Drug Discovery Growth Twist Bioscience (TWST) shares fell Thursday after a 2027 outlook signaled slower AI drug discovery growth, overshadowing a strong Q4 beat.
zacks.com Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates Twist Bioscience (TWST) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.45 per share a year ago.
benzinga.com Twist Bioscience Q4 2026 Earnings Call Transcript Twist Bioscience (NASDAQ:TWST) reported fourth-quarter financial results on Thursday. The transcript from the company’s fourth-quarter earnings call has been provided below.This transcript is brought…benzinga.com Twist Bioscience Q4 EPS $(0.32) Beats $(0.34) Estimate, Sales $126.644M Beat $123.085M Estimate Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 28.89 percent increase over losses of…
benzinga.com Twist Bioscience Sees FY2027 Sales $550.000M-$560.000M vs $547.137M Est Twist Bioscience (NASDAQ:TWST) sees FY2027 sales of $550.000 million-$560.000 million vs $547.137 million analyst estimate.
benzinga.com Twist Bioscience Sees Q1 Sales $130.000M-$132.000M vs $126.354M Est Twist Bioscience (NASDAQ:TWST) sees Q1 sales of $130.000 million-$132.000 million vs $126.354 million analyst estimate.
businesswire.com Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced financial results and business highlights for…
benzinga.com Cisco Systems, Applied Materials On Deck Thursday As AI Demand Faces Test Cisco Systems and Applied Materials headline Thursday’s reports, with investors looking for evidence that AI infrastructure demand can keep supporting semiconductor and networking growth. Brookfield,…
businesswire.com Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value…
businesswire.com Twist Bioscience to Present at Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that Emily M. Leproust, Ph.D., CEO and…
benzinga.com Twist Bioscience Stock Sinks as Bear Cave Raises Valuation Concerns Twist Bioscience Corp (NASDAQ:TWST) shares are plunging Thursday. The Bear Cave, which Hunterbrook Media owns, said that the life science tools company's stock price may have run ahead of its…benzinga.com Twist Bioscience Proposes Derivative Litigation Settlement Featuring Corporate Governance Reforms And $1M In Legal Fees SUMMARY NOTICE OF PROPOSED SETTLEMENT OF DERIVATIVE ACTIONTO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF TWIST BIOSCIENCE CORPORATION ("TWIST" OR THE "COMPANY") COMMON STOCK AS OF OCTOBER 15,
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
